MSN Laboratories has signed a license agreement with the Defence Research and Development Organization (DRDO) for the manufacturing, distribution and marketing of Covid-19 drug 2-DG in India.
MSN said it will be launching the drug under the brand name MSN 2D in sachet form as a twice a day product in strength of 2.24 g.
Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…